Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.18 USD | +7.31% | +17.68% | -0.57% |
Business Summary
Number of employees: 118
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ed Feener
FOU | Founder | 64 | 25/03/04 |
Ben Palleiko
CEO | Chief Executive Officer | 58 | 31/07/16 |
Paul Audhya
CTO | Chief Tech/Sci/R&D Officer | 51 | 02/05/21 |
Ryan Baker
IRC | Investor Relations Contact | - | 30/04/23 |
Nicole Sweeny
PRN | Corporate Officer/Principal | 49 | 24/07/23 |
Christopher Yea
PRN | Corporate Officer/Principal | 61 | 31/10/16 |
Mike Smith
PRN | Corporate Officer/Principal | - | 31/01/16 |
Rachel Morten
LAW | General Counsel | - | 31/12/15 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Brian Pereira
CHM | Chairman | 65 | 31/01/19 |
Ben Palleiko
CEO | Chief Executive Officer | 58 | 31/07/16 |
Albert Cha
BRD | Director/Board Member | 51 | 31/12/15 |
Edward Unkart
BRD | Director/Board Member | 74 | 30/11/14 |
Nancy Stuart
BRD | Director/Board Member | 65 | 17/03/21 |
Patrick Treanor
BRD | Director/Board Member | - | 25/05/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 42,188,296 | 41,706,792 ( 98.86 %) | 0 | 98.86 % |
Company contact information
KalVista Pharmaceuticals, Inc.
55 Cambridge Parkway Suite 901 East
02142, Cambridge
+857 999 0075
http://www.kalvista.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.57% | 514M | |
-3.93% | 86.16B | |
+2.76% | 40.17B | |
-16.48% | 31.47B | |
+53.80% | 25.24B | |
-13.58% | 15.82B | |
-9.12% | 11.96B | |
-15.71% | 11.89B | |
-42.56% | 11.61B | |
+4.79% | 8.84B |
- Stock Market
- Equities
- KALV Stock
- Company KalVista Pharmaceuticals, Inc.